Solid Biosciences
SLDB
55 hedge funds and large institutions have $466M invested in Solid Biosciences in 2024 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 2 reducing their positions, and 6 closing their positions.
1,100% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 2
356% more capital invested
Capital invested by funds: $102M → $466M (+$364M)
267% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 6
56% more call options, than puts
Call options by funds: $248K | Put options by funds: $159K
41% more funds holding
Funds holding: 39 → 55 (+16)
10.21% more ownership
Funds ownership: 82.45% → 92.66% (+10%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$31.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$23.8M |
| 3 |
DM
Deerfield Management
New York
|
+$21.2M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$16.9M |
| 5 |
AG
Artal Group
Luxembourg
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$8.71M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.08M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$901K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$28K |
| 5 |
A
AJOVista
Boston,
Massachusetts
|
-$23.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
First Manhattan
New York
| $1.77K | – | – | – |
|
|
52
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | -$28K | -2,994 | -98% |
|
53
Osaic Holdings
Scottsdale,
Arizona
| $399 | – | – | – |
|
|
PA
54
Parallel Advisors
San Francisco,
California
| $80 | – | – | – |
|
55
Macquarie Group
Sydney, NSW 2000,
Australia
| $17 | +$11.9K | +1,267 | New |
|
56
RhumbLine Advisers
Boston,
Massachusetts
| $13 | – | – | – |
|
|
CCM
57
Camber Capital Management
Boston,
Massachusetts
| – | -$8.71M | -1,418,439 | Closed |
|
|
58
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$901K | -131,500 | Closed |
|
|
A
59
AJOVista
Boston,
Massachusetts
| – | -$23.4K | -3,806 | Closed |
|
|
TRCT
60
Tower Research Capital (TRC)
New York
| – | -$9.55K | -1,555 | Closed |
|
61
Simplex Trading
Chicago,
Illinois
| – | -$5.03K | -537 | Closed |
|
62
Fidelity Investments
Boston,
Massachusetts
| – | -$37 | -6 | Closed |
|
SLDB Hedge Fund Activity: Q1 2024 in Review
55 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q1 2024, worth a combined $466M — up 356% from $102M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new SLDB positions and 6 closed out — a net gain of 16 holders — while 24 added to existing stakes and 2 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $31.9M. The largest seller was Camber Capital Management, exiting entirely with an estimated $8.71M sold.
- 55 institutional investors held Solid Biosciences (SLDB) as of Q1 2024, up from 39 in Q4 2023.
- Funds reported $466M of Solid Biosciences stock for Q1 2024, up 356% quarter-over-quarter.
- 22 funds opened new Solid Biosciences positions in Q1 2024 and 6 closed out, a net change of +16 holders.
- The largest Solid Biosciences buyer in Q1 2024 was Perceptive Advisors, an estimated $31.9M added.
- The largest Solid Biosciences seller in Q1 2024 was Camber Capital Management, an estimated $8.71M sold.
Based on aggregated 13F filings for Q1 2024.